These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9383377)
41. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735 [TBL] [Abstract][Full Text] [Related]
42. Thermodynamic studies of tyrosyl-phosphopeptide binding to the SH2 domain of p56lck. Lemmon MA; Ladbury JE Biochemistry; 1994 May; 33(17):5070-6. PubMed ID: 7513553 [TBL] [Abstract][Full Text] [Related]
43. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism. Dutartre H; Harris M; Olive D; Collette Y Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913 [TBL] [Abstract][Full Text] [Related]
44. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies. Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651 [TBL] [Abstract][Full Text] [Related]
45. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity. Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772 [TBL] [Abstract][Full Text] [Related]
46. Structural basis for the binding of high affinity phosphopeptides to Stat3. McMurray JS Biopolymers; 2008; 90(1):69-79. PubMed ID: 18058821 [TBL] [Abstract][Full Text] [Related]
47. The relationship between the pY+3 amino acid in the phosphopeptide ligands and the specificity for various SH2 domains. Lee KH; Park SH Protein Pept Lett; 2004 Dec; 11(6):527-32. PubMed ID: 15579120 [TBL] [Abstract][Full Text] [Related]
48. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains. Sheinerman FB; Al-Lazikani B; Honig B J Mol Biol; 2003 Dec; 334(4):823-41. PubMed ID: 14636606 [TBL] [Abstract][Full Text] [Related]
49. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation. Huyer G; Ramachandran C Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424 [TBL] [Abstract][Full Text] [Related]
50. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide. Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421 [TBL] [Abstract][Full Text] [Related]
51. Crystal structures of p120RasGAP N-terminal SH2 domain in its apo form and in complex with a p190RhoGAP phosphotyrosine peptide. Jaber Chehayeb R; Stiegler AL; Boggon TJ PLoS One; 2019; 14(12):e0226113. PubMed ID: 31891593 [TBL] [Abstract][Full Text] [Related]
52. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity. Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940 [TBL] [Abstract][Full Text] [Related]
53. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2. Huyer G; Li ZM; Adam M; Huckle WR; Ramachandran C Biochemistry; 1995 Jan; 34(3):1040-9. PubMed ID: 7530043 [TBL] [Abstract][Full Text] [Related]
54. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078 [TBL] [Abstract][Full Text] [Related]
55. A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group I SH2 domains. Songyang Z; Gish G; Mbamalu G; Pawson T; Cantley LC J Biol Chem; 1995 Nov; 270(44):26029-32. PubMed ID: 7592796 [TBL] [Abstract][Full Text] [Related]
56. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Waksman G; Shoelson SE; Pant N; Cowburn D; Kuriyan J Cell; 1993 Mar; 72(5):779-90. PubMed ID: 7680960 [TBL] [Abstract][Full Text] [Related]
57. Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain. Furet P; Gay B; García-Echeverría C; Rahuel J; Fretz H; Schoepfer J; Caravatti G J Med Chem; 1997 Oct; 40(22):3551-6. PubMed ID: 9357522 [TBL] [Abstract][Full Text] [Related]
58. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics. Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160 [TBL] [Abstract][Full Text] [Related]
59. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927 [TBL] [Abstract][Full Text] [Related]
60. Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase. Anselmi M; Calligari P; Hub JS; Tartaglia M; Bocchinfuso G; Stella L J Chem Inf Model; 2020 Jun; 60(6):3157-3171. PubMed ID: 32395997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]